|Bid||2.3600 x 3200|
|Ask||2.3700 x 1100|
|Day's Range||2.3500 - 2.5000|
|52 Week Range||2.1400 - 4.6500|
|Beta (3Y Monthly)||1.54|
|PE Ratio (TTM)||2.90|
|Earnings Date||Apr 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
PITTSBURGH, April 11, 2019 -- GNC Holdings, Inc. (NYSE: GNC), a leading global health and wellness brand, will release results for the first quarter of 2019 before the market.
TSX: BCB) has appointed William "Jamie" Jamieson as its global chief information officer. The appointment is effective immediately and Jamieson will report directly to Cott CEO Tom Harrington. In his role, Jamieson will lead the corporation’s global information technology function and play a key role in shaping the technology agenda across the Cott family of businesses.
A California firm is firing back at vitamin retailer General Nutrition Corporation (GNC), denying wrongdoing when it comes to a pair of stores in North Carolina – including one in Raleigh.
GNC Holdings’ general counsel for employment and franchising has joined the Pittsburgh office of Cozen O’Connor PC. Gary Kelly had worked at GNC (NYSE:GNC) since 2000, responsible for developing and implementing the health and fitness retailer’s legal policies and overseeing all litigation. The firm also hired Laura Reinhart, a Burns White member known for defending transportation companies in Federal Employment Liability Act-related litigation.
GNC Holdings Inc (NYSE:GNC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.
GNC Holdings Inc. shares slide about 14% Tuesday, after the vitamin and dietary supplement retailer posts weaker-than-expected earnings for the fourth quarter, offsetting news of a partnership that will garner it about $176 million.
Penguins' exec says new plan for former arena site featuring increases in office and retail space is "tenant driven" with new office tower estimated to range between 30 and 50 stories.
Please replace the release dated February 19, 2019 with the following corrected version due to multiple revisions.
With Alani Nutrition being a women-focused supplement brand, it is believed that the partnership might help GNC Holdings (GNC) widen its customer base.
PITTSBURGH , March 6, 2019 /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC), a leading global health and wellness brand, announced an exclusive retail and Amazon partnership with Alani Nutrition, a premium ...
IRVINE, Calif., March 5, 2019 /PRNewswire/ -- International Vitamin Corporation (IVC), a world leading nutritional supplement manufacturer announced today that it has formed a joint venture with GNC Holdings, Inc. (GNC), a leading global health and wellness brand, to integrate GNC's Nutra manufacturing division into IVC's operations. Nutra will be known as Nutra Manufacturing, LLC. Under the joint venture agreement, IVC will assume control of manufacturing and integrate into GNC's supply chain, while GNC teams will continue to support product development and innovation. Under the terms of the agreement, GNC will receive $101 million from IVC in exchange for an initial majority ownership in the joint venture. Over the next four years, GNC will receive an additional $75 million from IVC as IVC's ownership of the joint venture increases to 100% and Nutra Manufacturing, LLC becomes wholly owned by IVC.
fell Tuesday after the company posted weaker-than-expected earnings that offset the announcement of a new partnership with International Vitamin Corp. One of the milestones included the concurrent announcement of its joint venture with Irvine, Calif.-based International Vitamin, which will net GNC approximately $176 million over the next four years. As part of the deal, GNC said it will receive an aggregate $101 million in exchange for the net assets of International Vitamin's Nutra manufacturing plant and Anderson facility, and will retain an initial 43% in the venture.
GNC Holdings Inc. shares soared more than 3% in premarket trade before reversing those gains to trade down 3% Tuesday, after weaker-than-expected earnings offset news of a new venutre. The Pittsburgh, Pa.-based vitamin retail chain said it will receive about $176 million in a partnership with International Vitamin Corp. As part of the deal, GNC has agreed to integrate its manufacturing division with IVC through a joint venture. GNC will receive an aggregate $101 million in exchange for the net assets of the Nutra manufacturing plant and the Anderson facility and will retain an initial 43% in the venture. The company will receive an additional $75 million in the next four years based on the venture's performance as IVC's ownership stake rises to 100%. Separately, GNC said it had net income of $58.8 million, or 62 cents a share, in the fourth quarter, after a loss of $212.7 million, or $3.03 a share, in the year-earlier period, when it booked impairment charges. The company said it had an adjusted loss of 13 cents a share, compared with a FactSet consensus of EPS of 3 cents. Revenue fell to $547.9 million from $562.8 million, missing the FactSet consensus of $550.0 million. In February, the company completed the last tranche of the roughly $300 million investment by Harbin and used the proceeds to pay down debt and boost its capital position. "While fourth quarter operating results were below our expectations, we recently achieved some major milestones in repositioning the company," Chief Executive Ken Martindale said in a statement. Shares have fallen 24.4% in the last 12 months, while the S&P 500 has gained 2.6%.
Completed $300 million investment from Harbin Pharmaceutical Group ("Harbin")GNC to receive approximately $176 million ($101 million received in 2019) from International Vitamin.
Joint venture to generate meaningful manufacturing efficiencies and support GNC’s innovation and growth initiatives GNC to receive approximately $176 million ($101 million.
PITTSBURGH, March 04, 2019 -- GNC Holdings, Inc. (NYSE: GNC), a leading global health and wellness brand, will release results for the fourth quarter of 2018 before the market.
Analysts continue searching for a pulse at Rite Aid (NYSE:RAD), the embattled drug store chain. Even though quarterly sales are more than $5.4 billion, the RAD stock price has been below $1 per share since December.Source: Mike Mozart via FlickrAs the market cap hovers just above $802 million, management has proposed a reverse split of as much as 1:20 to buy time. With that time, Rite Aid is repositioning itself as a "wellness store," supported by a continuing partnership with GNC Holdings (NYSE:GNC), which offers a "store within a store" for its vitamins and supplements.CEO John Standley insists his chain is "healthy and relevant" in markets where it competes, mainly Pennsylvania and California, and it has a new CEO at its EnvisionRX pharmacy benefit manager.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Failed M&A Stripped AssetsTwo failed mergers in recent years have left Rite Aid a shadow of its former self. The company transferred more than 1,600 stores to Walgreens Boots Alliance (NYSE:WBA) last year for $3.6 billion, after a long-running effort to sell the whole company to Walgreens collapsed under the objection of regulators. But even after that move, it still has over $3.4 billion in long-term debt. * 10 Blue-Chip Stocks to Lead the Market Rite Aid then tried to merge with privately held Albertsons, which would have taken that grocer public. But that deal collapsed in August after some big RAD stock holders objected to the price.Walgreens has been converting some of the stores it bought to its own brand, closing others, while Rite Aid faces its own negative headlines as it tries to consolidate around its best performers. Other units are becoming dollar stores. Once National, Now RegionalWhile CVS Health (NYSE:CVS) and Walgreens sell for about half their annual sales, Rite Aid is worth less than 5% of its revenue. The chain is considered too small to compete. What was once a nationwide chain is now two regional chains, centered in Pennsylvania and California.EnvisionRX is also thought to be in an impossible situation, as insurers like UnitedHealth (NYSE:UNH) now have their own pharmacy benefit managers (PBM).But there is potential value there, albeit more than the public market is now willing to pay. Shareholders rejected a deal just six months ago that would have given them 29% of a $24 billion company. Rite Aid did pay $2 billion for Envision, and it's bigger now than it was then.While Cigna (NYSE:CI) now owns ExpressScripts, UnitedHealth owns the former Catamaran, and Aetna is under CVS, Humana (NYSE:HUM) still lacks a PBM and Anthem (NASDAQ:ANTM) is trying to create one from scratch. Analysts insist a deal is there to be had, somewhere. * 9 High-Growth Stocks to Buy Now for Monster Returns Rite Aid managers insist they need no deal. Add the debt to the equity, and Rite Aid has $4.5 billion in enterprise value. Analysts aren't expecting a profit for its current quarter, to be reported March 20, but a loss of three cents per share of RAD stock would be less than $40 million, on revenue of $5.56 billion. Management feels if it can turn a consistent profit, even on lower sales, the value should become clearer. Bottom Line on Rite Aid StockRite Aid is a minnow in a sea of sharks and it's going to be bought by someone.CEO Standley, in place since 2010, has most of his compensation tied up in RAD stock. There's no good reason for the company to disappear, even after it has been taken apart.If you're still stuck in Rite Aid stock, there's no reason not to wait and hope. But you really should have been paying attention earlier. Next time a buyer comes calling, hopefully Rite Aid can take the deal.Dana Blankenhorn is a financial and technology journalist. He is the author of a new mystery thriller, The Reluctant Detective Finds Her Family, available now at the Amazon Kindle store. Write him at firstname.lastname@example.org or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Consumer Stocks to Buy and Hold for Years * 4 China Stocks Soaring on Trade Hopes * 3 Esports Stocks to Benefit From the Boom Compare Brokers The post Rite Aid Stock Sits Below a Buck As Investors Search for a Pulse appeared first on InvestorPlace.